Abstract:The bioartificial liver (BAL) system can potentially rescue acute liver failure (ALF) patients by providing partial liver function until a suitable donor liver can be found or the native liver has self-regenerated. In this study, we established a suitable cryopreservation process for the development of an off-the-shelf BAL system. The viability of hepatocyte spheroids cryopreserved in liquid nitrogen was comparable to that of fresh primary hepatocyte spheroids. When hepatocyte spheroids were subjected to cryopreservation in a deep freezer, no statistically significant differences were observed in ammonia removal rate or urea secretion rate based on the cryopreservation period. However, the functional activity of the liver post-cryopreservation in a deep freezer was significantly lower than that observed following liquid nitrogen cryopreservation. Moreover, cryopreserving spheroid hydrogel beads in a deep freezer resulted in a significant decrease (approximately 30%) in both ammonia removal and urea secretion rates compared to the group cryopreserved in liquid nitrogen. The viabilities of spheroid hydrogel beads filled into the bioreactor of a BAL system were similar across all four groups. However, upon operating the BAL system for 24 h, the liver function activity was significantly higher in the group comprising hydrogel beads generated after thawing hepatocyte spheroids cryopreserved in liquid nitrogen. Consequently, the manufacturing of beads after the cryopreservation of hepatocyte spheroids is deemed the most suitable method, considering efficiency, economic feasibility, and liver function activity, for producing a BAL system.

What problem does this paper attempt to address?

This paper aims to solve the problem of cryopreservation of hepatocyte spheroids in the Bioartificial Liver (BAL) system, in order to achieve the efficient production of "off - the - shelf" BAL systems. Specifically, the main objective of the study is to determine the optimal cryopreservation stage and temperature so that it can be quickly thawed and integrated into the BAL system when needed for the emergency treatment of patients with Acute Liver Failure (ALF). ### Research Background Acute liver failure is a fatal disease. The mortality rate of patients without Liver Transplantation (LT) treatment is as high as 80 - 90%, and even after liver transplantation, the mortality rate is still more than 50%. The Bioartificial Liver Support System (BAL) aims to help ALF patients maintain their lives by providing partial liver functions until a suitable donor liver is found or their own liver regenerates. ### Research Purpose The main purpose of this study is to establish a cryopreservation process suitable for the "off - the - shelf" BAL system. Specifically, the study compared the effects of different cryopreservation methods on hepatocyte spheroids and their hydrogel beads to determine the most effective cryopreservation strategy. ### Research Methods The researchers designed four experimental groups and tested the following four cryopreservation methods respectively: 1. **SLNB**: Hepatocyte spheroids were cryopreserved in liquid nitrogen (-196°C), thawed and then prepared into hydrogel beads. 2. **SDFB**: Hepatocyte spheroids were cryopreserved in a deep - freeze refrigerator (-80°C), thawed and then prepared into hydrogel beads. 3. **BLN**: Hepatocyte spheroids were first prepared into hydrogel beads and then cryopreserved in liquid nitrogen. 4. **BDF**: Hepatocyte spheroids were first prepared into hydrogel beads and then cryopreserved in a deep - freeze refrigerator. ### Main Results 1. **Cell Survival Rate**: - The survival rate of hepatocyte spheroids cryopreserved in liquid nitrogen (SLN) was similar to that of fresh hepatocyte spheroids. - The survival rate of hepatocyte spheroids cryopreserved in a deep - freeze refrigerator (SDF) was significantly lower than that of fresh hepatocyte spheroids. 2. **Liver Function Indicators**: - Hepatocyte spheroids cryopreserved in liquid nitrogen performed better in terms of ammonia clearance rate and urea secretion rate. - Hepatocyte spheroids cryopreserved in a deep - freeze refrigerator showed a significant decline in these two indicators. 3. **BAL System Operation**: - During the 24 - hour operation process, the hydrogel beads prepared from hepatocyte spheroids cryopreserved in liquid nitrogen (SLNB) showed the highest liver function activity. - The hydrogel beads prepared from hepatocyte spheroids cryopreserved in a deep - freeze refrigerator (SDFB) performed fairly well within the first 10 hours, but then the liver function activity decreased significantly. ### Conclusion The research results show that cryopreserving hepatocyte spheroids in liquid nitrogen and then preparing them into hydrogel beads (SLNB) is the best method for producing "off - the - shelf" BAL systems. This method not only has advantages in terms of efficiency and economy, but also can maintain a relatively high liver function activity, which is suitable for the emergency treatment of patients with acute liver failure.

Selecting serum-free hepatocyte cryopreservation stage and storage temperature for the application of an "off-the-shelf" bioartificial liver system

Establishment of a Serum-Free Hepatocyte Cryopreservation Process for the Development of an “Off-the-Shelf” Bioartificial Liver System

Primary Throughput Screening of Protectants for Hypothermic Preservation of Bioartificial Liver in Gel Entrapped Hepatocytes

Advances in cell sources of hepatocytes for bioartificial liver.

Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.

Progress in bioreactors of bioartificial livers.

Experimental study of bioartificial liver with cultured human liver cells.

Configuration of a new bioartificial liver support system and in vitro evaluation of its functions.

Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver

Key Challenges to the Development of Extracorporeal Bioartificial Liver Support Systems

A New Fluidized Bed Bioreactor Based On Diversion-Type Microcapsule Suspension For Bioartificial Liver Systems

Cryoprotective Agent for Hepatocyte Cryopreservation, State of the Art

Bioinspired Artificial Liver System with hiPSC‐Derived Hepatocytes for Acute Liver Failure Treatment

A Simple Isolation and Cryopreservation Method for Adult Human Hepatocytes

Cryobiological aspects of upscaling cryopreservation for encapsulated liver cell therapies

Differential function of protective agents at each stage of the hypothermic preservation of hepatocytes

The Development of a New Bioartificial Liver and Its Application in 12 Acute Liver Failure Patients

Construction of a novel bioartificial liver system and its functional evaluation in vitro

Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System

Evaluation of Hydromechanical and Functional Properties of Diversion-Type Microcapsule-Suspension Bioreactor for Bioartificial Liver

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study